Press Release: Just. : Just - Evotec Biologics & Biocon Biologics Sign Licensing Deal For A Biosimilar Asset

BIOCON BIOLOGICS IN-LICENSES AN EARLY-STAGE BIOSIMILAR ASSET, WILL UNDERTAKE DEVELOPMENT, MANUFACTURING AND COMMERCIALISATION UNDER ITS OWN LABELJUST - EVOTEC BIOLOGICS HAS RECEIVED A LICENSE FEE AND WILL...